prostate cancer, benign prostate hyperplasia
Conditions
Brief summary
change of gut microbiota signature after two months of prostate medication (5-ARI, LhRH-analog/antagonist)
Detailed description
change of gut microbiota metabolism after two months of prostate medication (5-ARI, LhRH-analog/antagonist), PSA response to 5-ARI after 2 and 6 months of therapy, prostate volume change to 5-ARI treatment after 2 and 6 months of therapy, PSA response LhRH-analog/antagonist after 2 and 6 months of therapy
Interventions
DRUGDuodart 0
DRUG5 mg/0
DRUG4 mg hårda kapslar
DRUGFINASTERIDE
DRUGDUTASTERIDE
Sponsors
Turku University Central Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of gut microbiota signature after two months of prostate medication (5-ARI, LhRH-analog/antagonist) | — |
Secondary
| Measure | Time frame |
|---|---|
| change of gut microbiota metabolism after two months of prostate medication (5-ARI, LhRH-analog/antagonist), PSA response to 5-ARI after 2 and 6 months of therapy, prostate volume change to 5-ARI treatment after 2 and 6 months of therapy, PSA response LhRH-analog/antagonist after 2 and 6 months of therapy | — |
Countries
Finland
Outcome results
None listed